Daily briefings on HEOR, HTA strategy and the evidence access landscape. For pharmaceutical and biotech professionals navigating regulatory-payer alignment, HTA submissions, and evidence strategy. Hosted by Marcus and Sara.
Daily briefings on HEOR, HTA strategy and the evidence access landscape. For pharmaceutical and biotech professionals navigating regulatory-payer alignment, HTA submissions, and evidence strategy. Hosted by Marcus and Sara.
ISPOR Week: The Evidence Generation Timing Gap
May 12, 2026 • 4m
When The News Slows: Strategy Through Quiet Cycles
May 11, 2026 • 2m
MFN Agreements, Heart Failure Evidence, and JCA Timelines
May 11, 2026 • 4m
JCA at Sixteen Months, Survodutide Phase III, and ISPOR 2026
May 11, 2026 • 8m